Brimonidine Tartrate 62332-0749-05
- Manufacturer
- Alembic Pharmaceuticals Inc.
- Dosage Form
- Solution/ Drops
- Route
- Ophthalmic
- Product Type
- Human Prescription Drug
- Marketing Start
- August 1, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA216909
Need to source Brimonidine Tartrate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Brimonidine Tartrate | 1 mg/mL |
Drug Class
Adrenergic alpha-Agonists [MoA]alpha-Adrenergic Agonist [EPC]
Selected Package
62332-0749-05Selected1 BOTTLE in 1 CARTON (62332-749-05) / 5 mL in 1 BOTTLE
Other packages for this product(2)
1 BOTTLE in 1 CARTON (62332-749-10) / 10 mL in 1 BOTTLE
1 BOTTLE in 1 CARTON (62332-749-15) / 15 mL in 1 BOTTLE